期刊文献+

人肝癌细胞系Huh-7中CD133^+细胞的分离及鉴定 被引量:2

Isolation and identification of CD133^+ cells from human hepatocellular carcinoma cell lines Huh-7
下载PDF
导出
摘要 目的通过表面标志分选法富集人肝癌Huh-7细胞中CD133+细胞,并初步鉴定其特性。方法采用流式细胞分选技术从人肝癌细胞系Huh-7中分选出CD133+细胞,并进行干细胞比例分析;通过对CD133+细胞体外成球能力及增殖能力检测,考察CD133+细胞的自我更新能力;观察CD133+细胞在非肥胖性糖尿病/重度联合免疫缺陷小鼠(NOD/SCID)体内的成瘤情况。结果分选获得的CD133+细胞经无血清培养后阳性比例达90%以上;CD133+细胞体外无血清培养3 d即可成球且生长速度较CD133-细胞快;CD133+细胞在NOD/SCID小鼠体内21 d左右即可形成异种移植瘤。结论 CD133+表面标志物分选方法可以高纯度富集CD133+细胞,利用CD133抗体分选获得的CD133+细胞具有肿瘤干细胞样特性。 Objective To enrich CD133 + cells from human hepatocellular carcinoma cell lines Huh-7 cells through fluores- cence activated cell sorting and identify their biological characteristics. Methods CD133 + cells were sorted by flow cytometry and the percentage of them in cultured Huh-7 cells was analyzed. The self-renewing and sphere-forming ability of CD133 ~ cell were observed by light microscope in vitro in comparison with CD133 - cells. Tumor-forming ability of CD133 + cells was observed by xenografts of them in NOD/SCID mice. Results Flow cytometry analysis indicated that the purity of CD133 ~ subset cells exceeded 90% , CD133 ~ subset cells were verified multipotent with the ability of forming tumor spheres within 3 culture days. And CD133 + subset cells were higher proliferative in vitro and had higher tumorigenitic ability in vivo than those of CD133 - subset cells in mice for 21d. Conclusion CD133 + cells super marker sorting method can enrich CD133 + cells in high purity, and CD133 + cells sorted with CD133 antibody pos- sess the characteristics of tumor stem cells.
出处 《国际药学研究杂志》 CAS CSCD 2013年第2期198-202,共5页 Journal of International Pharmaceutical Research
基金 国家重点基础研究发展计划(973计划)资助项目(2010CB933904)
关键词 肿瘤干细胞 流式细胞分选 CD133抗体 tumor stem cells fluorescence-activated cell sorting anti-CD133 antibody
  • 相关文献

参考文献11

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859):105-111.
  • 2De Jonge-Peeters SD, Kuiper F, de Vries EG, et al.ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance [J]. Crit Rev Oncol Hematol, 2007, 62(3):214-226.
  • 3Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity[J]. Int J Cancer, 2007, 120(7):1444-1450.
  • 4Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells[J]. Gastroenterology, 2007, 132(7):2542-2556.
  • 5Yang W, Yan HX, Chen L, et al. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells[J]. Cancer Res, 2008, 68(11):4287-4295.
  • 6Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features[J]. Gastroenterology, 2009, 136(3):1012-1024.
  • 7Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J]. Cancer Res, 2005, 65(13):5506-5511.
  • 8Yin AH, Miraglia S, Zanjani ED, et al. AC133. a novel marker for human hematopoietic stem and progenitor cells[J]. Blood, 1997, 90(12):5002-5012.
  • 9Song W, Li H, Tao K, et al. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma[J]. Int J Clin Pract, 2008, 62(8):1212-1218.
  • 10Hadnagy A, Gaboury L, Beanlieu R, et al. SP analysis may be used to identify cancer stem cell populations[J]. Exp Cell Res, 2006, 312(19):3701-3710.

同被引文献27

  • 1Parkin D M.Global cancer statistics in the year 2000[J].Lancet Oncol,2001,58(2):533-543.
  • 2Li D W,Tang H M,Fan J W,et al.Expression level of Bmi-1oncoprotein is associated with progression and prognosis in colon cancer[J].J Cancer Res Clin Oncol,2010,136(7):997-1006.
  • 3Reya T,Morrison S J,Clarke M F.Stem cells,cancer and cancer stem cells[J].Nature,2001,414(6859):105-111.
  • 4Haraguchi N,Inoue H,Tanaka F,et al.Cancer stem cells in human gastrointestinal cancers[J].Hum Cell,2006,25(19):24-29.
  • 5O’Brien C A,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(58):106-110.
  • 6Song W,Tao K,Li H,et al.Bmi-1 is related to proliferation,survival and poor prognosis in pancreatic cancer[J].Cancer Sci,2010,101(7):1754-1760.
  • 7Wu J,Hu D,Yang G,et al.Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells[J].J Cell Biochem,2011,112(7):1938-1948.
  • 8Li H,Song F,Chen X,et al.Bmi-1 regulates epithelial-tomesenchymal transition to promote migration and invasion of breast cancer cells[J].Int J Clin Exp Pathol,2014,7(6):3057-3064.
  • 9徐丽姝.Bmi-1基因在结肠癌中的过度表达及其临床意义[J].中国老年学杂志,2008,28(22):2235-2237. 被引量:5
  • 10陈忠,步雪锋,毛须平,毛飞.胃癌中Bmi-1的表达及意义[J].中国实验诊断学,2011,15(2):326-327. 被引量:5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部